[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2014/47397,2014,A1Locationinpatent:Paragraph00185
[1]CurrentPatentAssignee:BRISTOL-MYERSSQUIBBCO-WO2015/5901,2015,A1Locationinpatent:Page/Pagecolumn540;541
[1]Patent:WO2015/180613,2015,A1
1260897-05-9
133261-33-3
1419101-45-3
1447943-53-4
175286-61-0
277756-44-2
1228280-29-2 | 5-(4-Methylbenzamido)-2-(phenylamino)thiazole-4-carboxamide | AA00A1D6 | MFCD29059915
139021-45-7 | 2-AMINO-1-(3-NITROPHENYL)ETHANOL HYDROCHLORIDE | AA00A2NL | MFCD09909504
1334136-60-5 | 5-Bromo-2-chloro-3-nitropyridin-4-amine | AA00A5HU | MFCD23131039
139139-56-3 | 2,2,5-Trimethylpiperazine | AA00A998 | MFCD11052516
1337880-84-8 | N-((6-Chloropyridazin-3-yl)methyl)cyclopropanamine hydrochloride | AA00AAFY | MFCD19982298
19031-56-2 | HEPTANEDIOIC-2,2,6,6-D4 ACID | AA00AB1A | MFCD01311694
19359-16-1 | N-Mesityl-3-oxobutanamide | AA00AB8B | MFCD00453329
1453848-26-4 | 1-[(1S)-1-(4-chloro-3-fluorophenyl)-2-hydroxyethyl]-4-{2-[(2-methylpyrazol-3-yl)amino]pyrimidin-4-yl}pyridin-2-one | AA00ABHF | MFCD28143918
152657-84-6 | NALFURAFINE | AA00ABLQ | MFCD09837714
191729-45-0 | Tenacissoside H | AA00ABQL | MFCD22125017